Sol-Gel

Sol-Gel Technologies is a dynamic clinical-stage dermatology company dedicated to the research, development, and commercialization of innovative branded and generic topical drug products for treating various skin diseases. Sol-Gel's commitment to advancing dermatological treatments positions it as a key player in the biotechnology sector. The company focuses on leveraging its expertise to deliver cutting-edge solutions that address significant unmet needs in dermatology.

Sol-Gel's pipeline includes late-stage branded product candidates utilizing its proprietary silica-based microencapsulation technology platform, alongside several generic product candidates across multiple indications. This unique technology enables drug substances to be entrapped in porous silica microcapsules, overcoming the limitations of topical drug delivery by stabilizing active drug ingredients, extending drug delivery time, and reducing potential irritation from direct skin application.

Located primarily at 7 Golda Meir st., Ness Ziona, IL and with an additional location at 110 S Jefferson Rd, Whippany, New Jersey 07981, US, Sol-Gel Technologies is poised for continued growth and innovation. We invite the management team at Sol-Gel Technologies to enhance your company’s profile by creating a customized and exclusive company showcase and product listing on our platform, to further amplify your reach and connect with a broader audience.